$QRVO
Qorvo Inc

2020 Q3 Form 10-Q Financial Statement

#000160477820000057 Filed on July 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $787.5M $775.6M
YoY Change 1.53% 11.97%
Cost Of Revenue $461.7M $481.3M
YoY Change -4.08% 5.56%
Gross Profit $325.8M $294.3M
YoY Change 10.7% 24.31%
Gross Profit Margin 41.37% 37.94%
Selling, General & Admin $86.60M $88.98M
YoY Change -2.67% -34.54%
% of Gross Profit 26.58% 30.24%
Research & Development $130.1M $118.9M
YoY Change 9.38% 7.23%
% of Gross Profit 39.92% 40.41%
Depreciation & Amortization $49.99M $63.90M
YoY Change -21.78% 47.07%
% of Gross Profit 15.34% 21.71%
Operating Expenses $233.1M $239.1M
YoY Change -2.5% -6.6%
Operating Profit $92.71M $55.23M
YoY Change 67.88% -387.41%
Interest Expense $18.85M $11.86M
YoY Change 58.88% -17.34%
% of Operating Profit 20.33% 21.48%
Other Income/Expense, Net $23.14M -$1.111M
YoY Change -2182.54% -96.52%
Pretax Income $97.00M $45.20M
YoY Change 114.6% -172.75%
Income Tax $100.0K $5.700M
% Of Pretax Income 0.1% 12.61%
Net Earnings $96.92M $39.54M
YoY Change 145.12% -231.83%
Net Earnings / Revenue 12.31% 5.1%
Basic Earnings Per Share $0.85 $0.33
Diluted Earnings Per Share $0.83 $0.33
COMMON SHARES
Basic Shares Outstanding 114.2M shares 114.6M shares 118.8M shares
Diluted Shares Outstanding 116.8M shares 121.1M shares

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.136B $629.6M
YoY Change 80.48% 60.61%
Cash & Equivalents $1.136B $629.6M
Short-Term Investments
Other Short-Term Assets $38.18M $34.37M
YoY Change 11.1% -0.54%
Inventory $523.7M $517.8M
Prepaid Expenses $43.80M $31.89M
Receivables $326.0M $326.7M
Other Receivables $11.40M $16.50M
Total Short-Term Assets $2.079B $1.557B
YoY Change 33.56% 13.83%
LONG-TERM ASSETS
Property, Plant & Equipment $1.236B $1.309B
YoY Change -5.64% -4.32%
Goodwill $2.615B $2.301B
YoY Change 13.66% 5.84%
Intangibles $738.3M $508.2M
YoY Change 45.3% -30.31%
Long-Term Investments $29.90M $98.00M
YoY Change -69.49% 23.27%
Other Assets $177.2M $153.0M
YoY Change 15.83% 141.37%
Total Long-Term Assets $4.803B $4.370B
YoY Change 9.93% -1.02%
TOTAL ASSETS
Total Short-Term Assets $2.079B $1.557B
Total Long-Term Assets $4.803B $4.370B
Total Assets $6.883B $5.926B
YoY Change 16.14% 2.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $225.9M $224.7M
YoY Change 0.52% 2.55%
Accrued Expenses $192.4M $168.6M
YoY Change 14.06% 26.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.587M $1.732M
YoY Change 280.31%
Total Short-Term Liabilities $509.3M $452.1M
YoY Change 12.65% 12.09%
LONG-TERM LIABILITIES
Long-Term Debt $1.870B $1.019B
YoY Change 83.54% 82.45%
Other Long-Term Liabilities $152.6M $118.3M
YoY Change 29.02% 12.19%
Total Long-Term Liabilities $152.6M $118.3M
YoY Change 29.02% 12.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $509.3M $452.1M
Total Long-Term Liabilities $152.6M $118.3M
Total Liabilities $2.531B $1.589B
YoY Change 59.31% 43.91%
SHAREHOLDERS EQUITY
Retained Earnings $49.23M -$281.5M
YoY Change -117.49% -41.86%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.351B $4.337B
YoY Change
Total Liabilities & Shareholders Equity $6.883B $5.926B
YoY Change 16.14% 2.49%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $96.92M $39.54M
YoY Change 145.12% -231.83%
Depreciation, Depletion And Amortization $49.99M $63.90M
YoY Change -21.78% 47.07%
Cash From Operating Activities $214.3M $257.1M
YoY Change -16.66% 241.64%
INVESTING ACTIVITIES
Capital Expenditures $29.83M $50.30M
YoY Change -40.69% 15.45%
Acquisitions -$155.0K $291.6M
YoY Change -100.05%
Other Investing Activities -$6.330M $2.236M
YoY Change -383.09% -74.2%
Cash From Investing Activities -$23.35M -$342.1M
YoY Change -93.18% 211.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $75.04M $100.1M
YoY Change -25.02% 0.07%
Debt Paid & Issued, Net $1.250M $0.00
YoY Change -100.0%
Cash From Financing Activities $229.8M $3.866M
YoY Change 5845.19% -100.7%
NET CHANGE
Cash From Operating Activities $214.3M $257.1M
Cash From Investing Activities -$23.35M -$342.1M
Cash From Financing Activities $229.8M $3.866M
Net Change In Cash $421.3M -$81.43M
YoY Change -617.34% -86.25%
FREE CASH FLOW
Cash From Operating Activities $214.3M $257.1M
Capital Expenditures $29.83M $50.30M
Free Cash Flow $184.4M $206.8M
YoY Change -10.82% 552.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-03
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001604778
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1415397000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1459728000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
288000 USD
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114625000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114354000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114625000 shares
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-06-27
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-36801
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5288992
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
Qorvo, Inc.
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
714939000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
325993000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1690502000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
225905000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
192353000 USD
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
7628 Thorndike Road
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Greensboro,
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27409-9421
CY2020Q2 dei City Area Code
CityAreaCode
336
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
664-1233
CY2020Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2020Q2 dei Trading Symbol
TradingSymbol
QRVO
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114236461 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1136302000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
367172000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
523690000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
517198000 USD
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
43795000 USD
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
37872000 USD
CY2020Q2 us-gaap Other Receivables
OtherReceivables
11369000 USD
CY2020Q1 us-gaap Other Receivables
OtherReceivables
15016000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
38180000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
38305000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
2079329000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1235676000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1259203000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
2615178000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
2614274000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
738346000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
808892000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
36921000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
22515000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
177236000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
165296000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
246954000 USD
CY2020Q2 us-gaap Assets
Assets
6882686000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
217801000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6587000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130071000 USD
CY2020Q1 us-gaap Assets
Assets
6560682000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
325789000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
294289000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6893000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
84487000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67355000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
509332000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
539003000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1869502000 USD
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1567231000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
152607000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
161783000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
2531441000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
2268017000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4293621000 USD
CY2020Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4290377000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8394000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2288000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
49230000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4351245000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4292665000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6882686000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6560682000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2019Q2 us-gaap Revenues
Revenues
775598000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461662000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
481309000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118920000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86604000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88979000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-16402000 USD
CY2019Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-31164000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
233077000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
239063000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
92712000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
55226000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
18849000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
11864000 USD
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
1190000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7588000 USD
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
2946000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
103028000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39484000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39541000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
6087000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-213000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1868000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21947000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1111000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
97000000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
45197000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5656000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39541000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114585000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118756000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116751000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121123000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-122000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-19000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-34000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6106000 USD
CY2020Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4290377000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2288000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4292665000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6106000 USD
CY2020Q2 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
-6065000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15758000 USD
CY2020Q2 rfmd Cumulativeeffectadoptionof Asu201613
CumulativeeffectadoptionofASU201613
-38000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75039000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20956000 USD
CY2020Q2 rfmd Other Retained Earnings Adjustment
OtherRetainedEarningsAdjustment
-20000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-7697000 USD
CY2019Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-609000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
214281000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
257118000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29832000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50295000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-155000 USD
CY2019Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
291551000 USD
CY2020Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2019Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1950000 USD
CY2020Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6330000 USD
CY2019Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2236000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23347000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342132000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000 USD
CY2019Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
306750000 USD
CY2019Q2 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
100000000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26812000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4337343000 USD
CY2019Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4625566000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2019Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100073000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6681000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-281542000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39541000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
49987000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
63904000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72128000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58366000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15705000 USD
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11015000 USD
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75039000 USD
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114354000 shares
CY2020Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4293621000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8394000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
49230000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4351245000 USD
CY2019Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4687455000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6624000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-321152000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
4359679000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39541000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57000 USD
CY2019Q2 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
-3576000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
14948000 USD
CY2019Q2 rfmd Cumulativeeffectadoptionof Asu201602
CumulativeeffectadoptionofASU201602
69000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100073000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
21859000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
24953000 USD
CY2020Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-8728000 USD
CY2019Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8296000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41029000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-57298000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7443000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6371000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
330000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-581000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-35329000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7564000 USD
CY2020Q2 rfmd Changein Capital Expenditures Incurredbut Not Paid
ChangeinCapitalExpendituresIncurredbutNotPaid
19530000 USD
CY2019Q2 rfmd Changein Capital Expenditures Incurredbut Not Paid
ChangeinCapitalExpendituresIncurredbutNotPaid
25270000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1136302000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
715612000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
711382000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136894000 USD
CY2020Q2 rfmd Finite Livedand Indefinite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedandIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
9773000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629950000 USD
CY2020Q2 rfmd Finite Livedand Indefinite Lived Intangible Assets Foreign Currency Translation Gain Loss Amortization
FiniteLivedandIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossAmortization
114000 USD
CY2020Q1 rfmd Finite Livedand Indefinite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedandIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
6064000 USD
CY2020Q1 rfmd Finite Livedand Indefinite Lived Intangible Assets Foreign Currency Translation Gain Loss Amortization
FiniteLivedandIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossAmortization
11000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10464000 USD
CY2019Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9379000 USD
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7835000 USD
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4806000 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3249000 USD
CY2019Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-634000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
229841000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3866000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
507000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-284000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
421282000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-81432000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
629599000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
592000 USD
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
351000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136894000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629950000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
117868000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
112671000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
257656000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
291028000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
148166000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
113499000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
523690000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
517198000 USD
CY2020Q2 rfmd Unamortizedpremiumandissuancecostsnet
Unamortizedpremiumandissuancecostsnet
2119000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
2614274000 USD
CY2020Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-1190000 USD
CY2020Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2094000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
2615178000 USD
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
621600000 USD
CY2020Q1 rfmd Unamortizedpremiumandissuancecostsnet
Unamortizedpremiumandissuancecostsnet
1532000 USD
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2367000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116751000 shares
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1714866000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
976520000 USD
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1810979000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1002087000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72100000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58400000 USD
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
29900000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
14200000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
15700000 USD
CY2020 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
18300000 USD
CY2020Q2 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
2800000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6587000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6893000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1869502000 USD
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1567231000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2019Q2 us-gaap Revenues
Revenues
775598000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
938000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
23969000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
1998000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
938000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
837000 USD
CY2020Q2 rfmd Restructuring Reserve Non Cash Activity
RestructuringReserveNonCashActivity
86000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2013000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2019Q2 us-gaap Revenues
Revenues
775598000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
92712000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
55226000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
18849000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
11864000 USD
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
1190000 USD
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
2946000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21947000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1111000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
97000000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
45197000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5700000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.125
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39541000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114585000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118756000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2166000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121123000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares

Files In Submission

Name View Source Status
0001604778-20-000057-index-headers.html Edgar Link pending
0001604778-20-000057-index.html Edgar Link pending
0001604778-20-000057.txt Edgar Link pending
0001604778-20-000057-xbrl.zip Edgar Link pending
exhibit31120200627.htm Edgar Link pending
exhibit31220200627.htm Edgar Link pending
exhibit32120200627.htm Edgar Link pending
exhibit32220200627.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qorvo2020062710-q.htm Edgar Link pending
qorvo2020062710-q_htm.xml Edgar Link completed
qorvoform8kimagefinala59.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rfmd-20200627.xsd Edgar Link pending
rfmd-20200627_cal.xml Edgar Link unprocessable
rfmd-20200627_def.xml Edgar Link unprocessable
rfmd-20200627_lab.xml Edgar Link unprocessable
rfmd-20200627_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending